Core Insights - BLKBRD Asset Management, LP sold its entire stake in Hims & Hers Health for an estimated $18.07 million, reflecting a significant exit from the investment [1][2][8] Company Overview - Hims & Hers Health operates a multi-specialty telehealth platform, integrating digital healthcare delivery with a variety of consumer wellness products [6] - The company focuses on recurring revenue through subscriptions and direct sales, supported by a strong digital infrastructure [6] - As of February 13, 2026, the company's market capitalization was $3.57 billion, with a revenue of $2.21 billion and a net income of $133.79 million [4] Stock Performance - Hims & Hers stock has seen a drastic decline, dropping from a high of $64 per share to around $15 per share by early March 2026, representing a 72.46% decrease over the past year [7][8] - The stock has underperformed the S&P 500 by 84.25 percentage points [8] Recent Developments - The decline in stock price was catalyzed by Novo Nordisk terminating its partnership with Hims & Hers for weight-loss drugs and subsequently suing the company for selling copycat products [10] - Hims & Hers was one of the most shorted midcap stocks by institutional investors in January 2026 [10]